We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ALPHA:ATHEXAlpha Bank S.A. Analysis

Data as of 2026-06-02 - not real-time

$372.58

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Alphabet’s stock is trading above its 20‑day simple moving average while still lagging the 50‑day average, indicating a short‑term bullish bias within a broader uptrend. The RSI hovers around the neutral 50‑point mark, the MACD histogram is negative and the signal line is bearish, yet volume is on the rise and the price is comfortably above the identified support level, leaving upside room toward the next resistance. Recent material news highlights a strong Q1 earnings beat, an aggressive AI growth narrative, and an upgraded price target to $435, all of which reinforce momentum.
Fundamentally, the company delivers robust revenue growth of over 20%, high gross and operating margins, and a solid cash position with a modest dividend payout that appears sustainable. However, the forward PE of roughly 28 versus an industry average of 17, and a DCF‑derived fair value far below current pricing, suggest the stock is materially overvalued. Elevated beta and 30‑day volatility add market risk, while regulatory scrutiny of big‑tech platforms remains a medium‑level concern. Investors should weigh the strong growth story against valuation stretch and risk factors when deciding on exposure.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Positive earnings beat and raised price target
  • Technical support holding with increasing volume
  • AI growth narrative driving investor optimism

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong fundamentals but valuation remains stretched
  • Potential regulatory headwinds for big‑tech
  • Beta and volatility suggest cautious positioning

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained revenue growth and high margins
  • Strategic AI and cloud expansion opportunities
  • Low dividend payout ratio supporting cash reinvestment

Key Metrics & Analysis

Financial Health

Revenue Growth21.80%
Profit Margin37.92%
P/E Ratio28.4
ROE38.88%
ROA14.64%
Debt/Equity20.03
P/B Ratio9.4
Op. Cash Flow$174.4B
Free Cash Flow$27.9B
Industry P/E17.0

Technical Analysis

TrendBullish
RSI49.3
Support$369.71
Resistance$404.47
MA 20$387.10
MA 50$346.39
MA 200$300.51
MACDBearish
VolumeIncreasing
Fear & Greed Index92.52

Valuation

Fair Value$76.63
Target Price$409.00
Upside/Downside9.78%
GradeOvervalued
TypeGrowth
Dividend Yield0.24%

Risk Assessment

Beta1.33
Volatility36.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.